Compare Travere Therapeutics Inc. Common Stock (TVTX) vs Williams-Sonoma, Inc. (WSM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Travere Therapeutics Inc. Common Stock vs Williams-Sonoma, Inc. — how do they compare? Travere Therapeutics Inc. Common Stock trades at $52.74 (market cap $4.88B), while Williams-Sonoma, Inc. trades at $243.14 (market cap $28.26B). The key difference: Williams-Sonoma, Inc. is far larger — about 5.8× Travere Therapeutics Inc. Common Stock's market cap, and Williams-Sonoma, Inc. pays a 1.27% dividend while Travere Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Travere Therapeutics Inc. Common Stock for 0 Days and Williams-Sonoma, Inc. for 59 Days on average.
| TVTX | WSM | |
|---|---|---|
Market Cap | $4.88B | $28.26B |
Volume | 1,668,577 | 1,108,410 |
Sector | Health | Consumer Cyclical |
52-Week High | $67.52 | $251.81 |
52-Week Low | $26.79 | $168.64 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $5.01B | $28.76B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Williams-Sonoma (WSM) trades at $242.48, up 1.52% recently, with a bullish technical outlook and strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Profitability remains robust, with a net income margin of 14.73% and ROE of 54.96%, while valuation ratios like P/E of 24.61 and P/S of 3.62 reflect market confidence. Recent news highlights growth through minimal discounting and AI integration, supporting positive sentiment.
The outlook for WSM is favorable, driven by earnings momentum and market share gains, but risks include housing market sensitivity and competitive pressures. Analyst consensus leans hold with a $246.31 price target, suggesting modest upside. Institutional interest is steady, though insider selling warrants monitoring. Overall, the stock presents a balanced opportunity with growth potential tempered by sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Travere Therapeutics Inc. Common Stock
Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →About Williams-Sonoma, Inc.
With a wide retail and direct-to-consumer presence, Williams-Sonoma is a leader in the $300 billion domestic home category, focused on expanding its exposure in the B2B, marketplace, and franchise areas. Namesake Williams-Sonoma (175 stores) offers high-end cooking essentials, while Pottery Barn (189) provides casual home accessories. Brand extensions include Pottery Barn Kids (52) and PBteen. West Elm (121) is an emerging concept for young professionals, and Rejuvenation (9) offers lighting and house parts. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.
Read more on WSM →
